(Q43144574)

English

Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences

scientific article published on 2 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Ischemic colitis and complications of constipation associated with the use of alosetron under a risk management plan: clinical characteristics, outcomes, and incidences (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1 reference

based on heuristic

inferred from title

ischemic colitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lin Chang

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Kenneth Tong

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Vanessa Ameen

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

0 references

publication date

2 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

866-875

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

AGA technical review on intestinal ischemia. American Gastrointestinal Association

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

A patient follow-up survey programme for alosetron: assessing compliance to and effectiveness of the risk management programme.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Outcome of patients with ischemic colitis: review of fifty-three cases

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Ischemic colitis in postmenopausal women taking hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Ischemic colitis associated with naratriptan and oral contraceptive use.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Colonic ischemia associated with naratriptan use.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Ischemic colitis and sumatriptan use.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Ischemic colitis associated with rofecoxib.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Risk factors for colon ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Clinical features in young adult patients with ischaemic colitis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

AGA technical review on constipation. American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Intestinal non-rotation and pseudoobstruction in myotonic dystrophy: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Clinical significance of colonoscopic findings associated with colonic thickening on computed tomography: is colonoscopy warranted when thickening is detected?

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex).

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Impact of 5-HT3 receptor blockade on colonic haemodynamic responses to ischaemia and reperfusion in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Occurrence of colon ischemia in relation to irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Limitations and strengths of spontaneous reports data

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.25

21 January 2018

Identifiers

10.1038/AJG.2010.25

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43144574&oldid=1981589848"